FDA Inspection 1235013 - Rachel Layman, M.D. - February 29, 2024

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns Rachel Layman, M.D., with an inspection on February 29, 2024, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Rachel Layman, M.D.
Inspection Date: February 29, 2024
Product Type: Drugs
Office: Center for Drug Evaluation and Research

Open in Dashboard

ID · 77821460-2e93-47e3-83c9-113877cdc228